Glioma-initiating cells and molecular pathology: implications for therapy
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Atsushi Natsume Sayano Kinjo Kanako Yuki Takenori Kato Masasuke Ohno Kazuya Motomura Kenichiro Iwami Toshihiko Wakabayashi
- چاپ و سال / کشور: 2011
Description
There is now compelling evidence that gliomas harbor a small population of cells, termed glioma-initiating cells (GICs), characterized by their ability to undergo selfrenewal and initiate tumorigenesis. The development of therapeutic strategies targeted toward GIC signaling may improve the treatment of malignant gliomas. The characterization of GICs provides a clue to elucidating histological heterogeneity and treatment failure. The role of the stem cell marker CD133 in the initiation and progression of brain tumors is still uncertain. Here, we review some of the signaling mechanisms involved in GIC biology, such as phosphatase and tensin homolog (PTEN), sonic hedgehog, Notch, and WNT signaling pathways, maternal embryonic leucine-zipper kinase (MELK), BMI1, and Janus kinase signal transducer and activator of transcription (JAKSTAT) signaling. In addition, we discuss the role of microRNAs in GICs by focusing on microRNA-21 regulation by type I interferon.
Brain Tumor Pathol (2011) 28:1–12 DOI 10.1007/s10014-010-0011-3 Received: 30 August 2010 / Accepted: 25 October 2010 / Published online: 28 January 2011 The Japan Society of Brain Tumor Pathology 201
